AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52
LICHEN-PLANUS ASSOCIATED WITH BECKERS NEVUS
Authors: TERHEYDEN P HORNSCHUH B KARL S BECKER JC BROCKER EB
Citation: P. Terheyden et al., LICHEN-PLANUS ASSOCIATED WITH BECKERS NEVUS, Journal of the American Academy of Dermatology, 38(5), 1998, pp. 770-772
IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY
Authors: LODE HN XIANG R BECKER JC GILLIES SD REISFELD RA
Citation: Hn. Lode et al., IMMUNOCYTOKINES - A PROMISING APPROACH TO CANCER-IMMUNOTHERAPY, Pharmacology & therapeutics (Oxford), 80(3), 1998, pp. 277-292
SHAKEN BABY SYNDROME - REPORT ON 4 PAIRS OF TWINS
Authors: BECKER JC LIERSCH R TAUTZ C SCHLUETER B ANDLER W
Citation: Jc. Becker et al., SHAKEN BABY SYNDROME - REPORT ON 4 PAIRS OF TWINS, Child abuse & neglect, 22(9), 1998, pp. 931-937
THE EFFECT OF HELICOBACTER-PYLORI INFECTION ON GASTRIC ADAPTATION TO CHRONIC ASPIRIN INTAKE IN MAN
Authors: FISCHER H HUBER V BECKER JC BOKNIK P LUSS H NEUMANN J SCHMITZ W DOMSCHKE W KONTUREK JW
Citation: H. Fischer et al., THE EFFECT OF HELICOBACTER-PYLORI INFECTION ON GASTRIC ADAPTATION TO CHRONIC ASPIRIN INTAKE IN MAN, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 648-648
ACTIVATION OF PREEXISTING T-CELL CLONES BY TARGETED INTERLEUKIN-2 THERAPY
Authors: STRATEN PT GULDBERG P SEREMET T REISFELD RA ZEUTHEN J BECKER JC
Citation: Pt. Straten et al., ACTIVATION OF PREEXISTING T-CELL CLONES BY TARGETED INTERLEUKIN-2 THERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 95(15), 1998, pp. 8785-8790
AXIOMS FOR BUNDLE TRANSFERS AND TRACES
Authors: BECKER JC SCHULTZ RE
Citation: Jc. Becker et Re. Schultz, AXIOMS FOR BUNDLE TRANSFERS AND TRACES, Mathematische Zeitschrift, 227(4), 1998, pp. 583-605
IMMUNE-RESPONSE AGAINST HUMAN PRIMARY MALIGNANT-MELANOMA - A DISTINCTCYTOKINE MESSENGER-RNA PROFILE ASSOCIATED WITH SPONTANEOUS REGRESSION
Authors: WAGNER SN SCHULTEWOLTER T WAGNER C BRIEDIGKEIT L BECKER JC KWASNICKA HM GOOS M
Citation: Sn. Wagner et al., IMMUNE-RESPONSE AGAINST HUMAN PRIMARY MALIGNANT-MELANOMA - A DISTINCTCYTOKINE MESSENGER-RNA PROFILE ASSOCIATED WITH SPONTANEOUS REGRESSION, Laboratory investigation, 78(5), 1998, pp. 541-550
EARLY EXPERIENCE WITH PENNSYLVANIA AGRICULTURAL CONSERVATION EASEMENTPROGRAM
Authors: MAYNARD LJ KELSEY TW LEMBECK SM BECKER JC
Citation: Lj. Maynard et al., EARLY EXPERIENCE WITH PENNSYLVANIA AGRICULTURAL CONSERVATION EASEMENTPROGRAM, Journal of soil and water conservation, 53(2), 1998, pp. 106-112
IN-SITU DETECTION OF A CLONAL T-CELL RESPONSE DIRECTED AGAINST NEOPLASTIC AS WELL AS NORMAL MELANOCYTIC CELLS
Authors: BECKER JC GULDBURG P ZEUTHEN J BROCKER EB STRATEN PT
Citation: Jc. Becker et al., IN-SITU DETECTION OF A CLONAL T-CELL RESPONSE DIRECTED AGAINST NEOPLASTIC AS WELL AS NORMAL MELANOCYTIC CELLS, Journal of investigative dermatology, 110(4), 1998, pp. 635-635
IMMUNOCHEMOTHERAPY OF METASTATIC UVEAL MELANOMA WITH INTERFERON-ALPHA-2B, INTERLEUKIN-2, AND FOTEMUSTINE - CASE-REPORTS AND LITERATURE-REVIEW
Authors: TERHEYDEN P KAMPGEN E RUNGER TM BROCKER EB BECKER JC
Citation: P. Terheyden et al., IMMUNOCHEMOTHERAPY OF METASTATIC UVEAL MELANOMA WITH INTERFERON-ALPHA-2B, INTERLEUKIN-2, AND FOTEMUSTINE - CASE-REPORTS AND LITERATURE-REVIEW, Hautarzt, 49(10), 1998, pp. 770-773
IMMUNOCHEMOTHERAPY OF METASTATIC MALIGNAN T-MELANOMA WITH EPIFOCAL DNCB AND SYSTEMIC DTIC
Authors: TRCKA J KAMPGEN E BECKER JC SCHWAAF A BROCKER EB
Citation: J. Trcka et al., IMMUNOCHEMOTHERAPY OF METASTATIC MALIGNAN T-MELANOMA WITH EPIFOCAL DNCB AND SYSTEMIC DTIC, Hautarzt, 49(1), 1998, pp. 17-22
EPIFOCAL IMMUNOTHERAPY WITH DNCB COMBINED WITH SYSTEMIC DTIC-CHEMOTHERAPY IS A WELL TOLERATED, IN EXPENSIVE AND EFFECTIVE TREATMENT OF METASTATIC MELANOMA
Authors: TRCKA J KAMPGEN E BECKER JC BROCKER EB
Citation: J. Trcka et al., EPIFOCAL IMMUNOTHERAPY WITH DNCB COMBINED WITH SYSTEMIC DTIC-CHEMOTHERAPY IS A WELL TOLERATED, IN EXPENSIVE AND EFFECTIVE TREATMENT OF METASTATIC MELANOMA, British Journal of Cancer, 77, 1998, pp. 77-77
MOLECULAR-BASIS OF T-CELL DYSFUNCTION IN MELANOMA
Authors: BECKER JC TERHEYDEN P BROCKER EB
Citation: Jc. Becker et al., MOLECULAR-BASIS OF T-CELL DYSFUNCTION IN MELANOMA, Melanoma research, 7, 1997, pp. 51-57
IMMUNOCYTOKINES - A NEW APPROACH TO IMMUNOTHERAPY OF MELANOMA
Authors: REISFELD RA BECKER JC GILLIES SD
Citation: Ra. Reisfeld et al., IMMUNOCYTOKINES - A NEW APPROACH TO IMMUNOTHERAPY OF MELANOMA, Melanoma research, 7, 1997, pp. 99-106
IN-SITU CYTOKINE THERAPY BY IMMUNOKINES - INDUCTION OF T-CELL MEDIATED ANTITUMOR IMMUNITY
Authors: BECKER JC BROCKER EB REISFELD RA
Citation: Jc. Becker et al., IN-SITU CYTOKINE THERAPY BY IMMUNOKINES - INDUCTION OF T-CELL MEDIATED ANTITUMOR IMMUNITY, European journal of cancer, 33, 1997, pp. 28-28
DISTRIBUTED COMPUTING FOR MULTIDISCIPLINARY DESIGN OPTIMIZATION USINGJAVA
Authors: BECKER JC BLOEBAUM CL HULME KF
Citation: Jc. Becker et al., DISTRIBUTED COMPUTING FOR MULTIDISCIPLINARY DESIGN OPTIMIZATION USINGJAVA, Structural optimization, 14(4), 1997, pp. 203-218
DIFFERENTIAL-EFFECTS OF ARGATROBAN AND HEPARIN ON HEMOCHRON AND HEMOTEC ACTIVATED CLOTTING TIMES IN PATIENTS UNDERGOING CORONARY INTERVENTIONAL PROCEDURES
Authors: HURSTING MJ BECKER JC LEWIS BE IQBAL O WALENGA JM FERGUSON JJ
Citation: Mj. Hursting et al., DIFFERENTIAL-EFFECTS OF ARGATROBAN AND HEPARIN ON HEMOCHRON AND HEMOTEC ACTIVATED CLOTTING TIMES IN PATIENTS UNDERGOING CORONARY INTERVENTIONAL PROCEDURES, Journal of the American College of Cardiology, 29(2), 1997, pp. 8211-8211
COMPARATIVE-STUDIES ON THE BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIESOF A MAJOR METABOLITE OF ARGATROBAN (M1) - POTENTIAL CLINICAL IMPLICATIONS
Authors: AHSAN A AHMAD S IQBAL O SCHWARZ R KNAPPENBERGER G JOFFRION J BECKER JC MESSMORE H
Citation: A. Ahsan et al., COMPARATIVE-STUDIES ON THE BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIESOF A MAJOR METABOLITE OF ARGATROBAN (M1) - POTENTIAL CLINICAL IMPLICATIONS, Thrombosis and haemostasis, 1997, pp. 370-370
EFFECT OF HEPATIC-FUNCTION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN
Authors: HURSTING MJ BECKER JC JOFFRION JL KNAPPENBERGER GD SCHWARZ RP
Citation: Mj. Hursting et al., EFFECT OF HEPATIC-FUNCTION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN, Thrombosis and haemostasis, 1997, pp. 2017-2017
PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN IN PATIENTS UNDERGOING ANTICOAGULANT TREATMENT AND CORONARY ANGIOPLASTY
Authors: AHMAD S AHSAN A GEORGE M WYMA D SCHWARZ R KNAPPENBERGER G JOFFRION J BECKER JC MESSMORE H
Citation: S. Ahmad et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ARGATROBAN IN PATIENTS UNDERGOING ANTICOAGULANT TREATMENT AND CORONARY ANGIOPLASTY, Thrombosis and haemostasis, 1997, pp. 2412-2412
EXPRESSION OF NITRIC-OXIDE SYNTHASE (NOS) IN HUMAN AND RAT GASTRIC TISSUE
Authors: FISCHER H BECKER JC BOKNIK P HUBER V KONTUREK JW LUSS H NEUMANN J SCHMITZ W DOMSCHKE W
Citation: H. Fischer et al., EXPRESSION OF NITRIC-OXIDE SYNTHASE (NOS) IN HUMAN AND RAT GASTRIC TISSUE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 496-496
IN-SITU CYTOKINE THERAPY BY IMMUNOKINES - INDUCTION OF T-CELL MEDIATED ANTITUMOR IMMUNITY
Authors: BECKER JC BROCKER EB REISFELD RA
Citation: Jc. Becker et al., IN-SITU CYTOKINE THERAPY BY IMMUNOKINES - INDUCTION OF T-CELL MEDIATED ANTITUMOR IMMUNITY, Journal of investigative dermatology, 108(4), 1997, pp. 569-569
CLINICAL EFFECT OF CONCURRENT WARFARIN ON THE EFFICACY OF ARGATROBAN THERAPY IN HEPARIN-INDUCED THROMBOCYTOPENIA
Authors: BECKER JC HURSTING MJ JOFFRION JL KNAPPENBERGER GD LEWIS BE SCHWARZ RP
Citation: Jc. Becker et al., CLINICAL EFFECT OF CONCURRENT WARFARIN ON THE EFFICACY OF ARGATROBAN THERAPY IN HEPARIN-INDUCED THROMBOCYTOPENIA, Blood, 90(10), 1997, pp. 3205-3205
MONITORING WARFARIN DURING CONCURRENT ARGATROBAN THERAPY IN HEALTHY-VOLUNTEERS - USE OF THE INTERNATIONAL NORMALIZED RATIO VERSUS FACTOR-X BY AMIDOLYTIC ASSAY
Authors: HURSTING MJ BECKER JC JOFFRION JL KNAPPENBERGER GD SCHWARZ RP
Citation: Mj. Hursting et al., MONITORING WARFARIN DURING CONCURRENT ARGATROBAN THERAPY IN HEALTHY-VOLUNTEERS - USE OF THE INTERNATIONAL NORMALIZED RATIO VERSUS FACTOR-X BY AMIDOLYTIC ASSAY, Blood, 90(10), 1997, pp. 3231-3231
PREDICTING WARFARINS CONTRIBUTION TO THE INTERNATIONAL NORMALIZATION RATIO DURING CONCURRENT ARGATROBAN THERAPY
Authors: HURSTING MJ BECKER JC JOFFRION JL KNAPPENBERGER GD SCHWARZ RP
Citation: Mj. Hursting et al., PREDICTING WARFARINS CONTRIBUTION TO THE INTERNATIONAL NORMALIZATION RATIO DURING CONCURRENT ARGATROBAN THERAPY, Blood, 90(10), 1997, pp. 3232-3232
Risultati: 1-25 | 26-50 | 51-52